Qualitative Assessment of the Progesterone Receptor and HER2 Improves the Nottingham Prognostic Index Up to 5 Years After Breast Cancer Diagnosis

Assessing the Value of Risk Predictions by Using Risk Stratification Tables

(2013) Holly Janes et al.   ANNALS OF INTERNAL MEDICINE

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The Nottingham Prognostic Index for Invasive Carcinoma of the Breast

(2009) Andrew H. S. Lee et al.   PATHOLOGY & ONCOLOGY RESEARCH

Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors

(2008) Olivier Brouckaert et al.   BREAST CANCER RESEARCH AND TREATMENT

Does Estrogen Receptor–Negative/Progesterone Receptor–Positive Breast Carcinoma Exist?

(2008) Leen De Maeyer et al.   JOURNAL OF CLINICAL ONCOLOGY

Are gene signatures better than traditional clinical factors?

(2008) Patrick Neven et al.   LANCET ONCOLOGY